---

Mark C. Fishman

President, Novartis Institutes for Biomedical Research

The aim of Novartis Institutes for Biomedical Research is to identify and advance promising drug candidates. Before joining Novartis in 2002, Mark was Chief of Cardiology and Director of the Cardiovascular Research Center at Massachusetts General Hospital, and Professor of Medicine at Harvard Medical School.

www.novartis.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015